BACKGROUND: Heart valve disease is a significant and increasing global problem in the developing world. The aim of this study is to evaluate the incidence of postoperative complications and mortality in patients who underwent heart valve replacement.
Introduction
Valvular heart disease (VHD) is one of the most important cardiovascular diseases which its prevalence differs regarding age; gender and different societies. 1 There are various etiologies of VHD including rheumatic, degenerative, traumatic, congenital, and infectious heart diseases. VHD remains common in developing countries, because the increase in prevalence of rheumatic heart diseases. 2 Rheumatic heart disease is caused by infection with group A beta-hemolytic streptococcus bacteria, and it occurs when the patient does not receive proper medical treatment. The prevalence of VHD has been also increased during the past years in industrialized countries due to increase in prevalence of degenerative valve diseases. 3 Surgery performs a main role in order to treat the patients with VHDs, which lead to less
Original Article
mortality and better quality-of-life. Heart valve replacement is the second most common type of heart surgery after coronary artery bypass graft surgery. 4 Different postoperative complications are associated with this procedure. In past studies, the rate of mortality following heart valve replacement was reported from 4.3% to 14%. 1 There are different rates of prevalence and incidence of VHDs between industrialized and developing countries and limited number of studies have been conducted regarding VHDs in Iran as a developing country, therefore, we conducted this study in order to determine the rates of postoperative complications and mortality in patients underwent heart valve replacement surgery in one of the tertiary center in our country.
Materials and Methods
After approval of the study protocol was granted by the Institutional Review Board, this prospective cross-sectional study was conducted at Rajaie Cardiovascular Medical and Research Center, Tehran, Iran, from June 2011 to January 2012. This paper represents the results of the dissertation. There were 436 cases that underwent heart valve replacement surgery during this time interval; however 116 patients were excluded from this study due to exclusion criteria including concomitant coronary artery bypass graft surgery or other cardiac operations and simultaneous repair of complex congenital heart defects. Therefore, 320 adult cases (186 female and 134 male patients) with a mean age of: 45.7 ± 15.0 were enrolled in this study. The data gathering forms were designed based on scoring system for reporting mortality and morbidity after cardiac valve interventions, European association for cardio-thoracic surgery. 5 All the required data, including present and history of the patients, echocardiographic data and preoperative and postoperative electrocardiogram parameters were studied. Mortality was occurred in 25 patients (7.8%) before discharge due to cardiac problems:10 cases (3.1%) including arrhythmia: 6 patients (1.9%), heart failure and cardiogenic shock: 4 cases (1.3%) and noncardiac problems: 15 cases (4.7%) including bleeding due to coagulopathy: 6 patients (1.9%), CVA or encephalopathy: 2 cases (0.6%), respiratory failure: 3 cases (0.9%), septicemia: 3 cases (0.9%) and multi-organ failure: 1 (0.3%). The relationships between the incidence of postoperative mortality and different factors including demographic data and type of the repaired valve have been demonstrated in tables 4 and 5. 
Discussion
The burden of heart valve disease among adults is enormous in the developing countries. The high prevalence of rheumatic heart disease remains the predominant contributor to heart valve dysfunction, which if uncorrected lead to congestive heart failure and increased morbidity and mortality. Heart valve replacement is the second most common type of heart surgery after coronary artery bypass graft surgery. 4 Geissler et al. declared in their study that 30,000 heart valve replacement surgeries are performed annually due to increase in prevalence of degenerative valve diseases in developed countries. 5 Regarding the increased rate of this type of procedure in this study we evaluated the incidence of complications and mortality following heart valve replacement surgery. Regarding the risk model to predict the incidence of mortality and morbidity after aortic and/or mitral valve replacement or repair in the study of Ambler et al. the significant factors were age, gender, female, BMI > 20 kg/m 2 , renal failure, HTN, diabetes, arrhythmia, EF and the number of previous cardiac surgeries. 6 Similar to our study, the incidence of postoperative events were higher in female patients. In contrast to the study of Ambler et al. the incidence of valve-related events was significantly higher in group of patients with age 25-45 years. 6 The mentioned result may be due to more mitral valve replacement requirement in younger adults that essentially accompanies more complications compared with aortic and pulmonary valve replacement. However, there was no significant relation between preoperative LV EF, type of the prosthetic valve, the number of previous cardiac operations and the incidence of postoperative events. In the study of Shahian et al. 7 and O'Brien et al. 8 the incidence of mortality following heart valve replacement surgery was 4.3-14.0%. In our study, this criteria was occurred in 7.8% of the cases. In the study of Shinn et al. mortality rate was reported in 6.9% of cases who underwent heart valve replacement surgery, and the contributor factors were old age, preoperative renal failure, postoperative pulmonary events and stroke. 9 Based on European system for cardiac operative risk evaluation (Euroscore), significant factors for the incidence of mortality and morbidity following heart valve replacement surgery are: old age, female gender, chronic obstructive pulmonary disease, neurologic dysfunction, history of recent cardiac surgery, renal dysfunction, impaired ventricular function, emergency cardiac surgery, and pulmonary HTN. In our study, mortality rate was higher in female group with no significant difference. The incidence of mortality was significantly more in old age group (age > 75 years) and patients who underwent emergent procedures. There was a statistically significant relation between the incidence of mortality and the history of HTN and diabetes. Also the type of the prosthetic valve, the anatomic site of the repaired valve and the number of repaired valves were reported as the significant factors for the incidence of mortality. 7, 8 In contrast, in our study, no significant relation was reported between the incidence of mortality and the mentioned factors. This difference may be due to the different study population in the study by Shahian et al. 7 The cases in the study of Shahian et al. underwent valve replacement surgery in addition to coronary artery bypass grafting. 7
Conclusion
Based on the results, age, presence of DM, HTN, high grade of functional capacity and multivalve disease are significant predictors of post-valvular replacement morbidity and mortality.
